Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2021-12-22 Regulatory Filings
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Cessation
Regulatory Filings Classification · 95% confidence The document text is extremely short (197 characters) and contains no substantive content, only placeholders for images and a mention of 'Annexure -A'. There is no financial data, no report title, no regulatory references, and no indication of the document being a full report. Given the brevity and lack of content, this is likely a supplementary or placeholder document, or an announcement-type document without substantive report content. According to the rules, such short documents that do not contain actual report data should be classified as Regulatory Filings (RNS) as a fallback category.
2021-12-22 English
Credit Rating
Regulatory Filings
2021-12-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (231 characters) and contains no substantive financial data, analysis, or detailed information. It appears to be a brief note or header with a date and organizer name, without any report content or detailed announcement. There is no indication of a full report, financial statements, or detailed disclosures. Given the brevity and lack of content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-12-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (170 characters) and contains no substantive financial data, analysis, or detailed information. It only includes a date and organizer name, with no report content or financial results. There is no indication of a full report, presentation, or announcement of voting results. Given the brevity and lack of content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-11-15 English
Press Release
Regulatory Filings
2021-10-26 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Results Presentation of the Company for the quarter and half-year ended September 30, 2021' and contains detailed financial data including quarterly and half-yearly financial highlights, segmental performance, consolidated profit & loss, and balance sheet data. It is a presentation format with forward-looking statements and executive commentary. The document is not merely an announcement of results but includes substantive financial data and analysis for the quarter and half-year period. This matches the definition of an Interim / Quarterly Report (IR), which covers comprehensive financial reports for periods shorter than a full fiscal year with actual financial statements and analysis. The document is not a brief earnings release (ER) as it contains detailed financial tables and segmental analysis, nor is it an investor presentation (IP) as it focuses primarily on financial results rather than broader strategy or market position. Therefore, the correct classification is IR with high confidence.
2021-10-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.